Literature DB >> 21676396

The 981C>T polymorphism in protein tyrosine phosphatase 1B is associated with decreased risk of coronary artery disease in Chinese Han population.

Xiang Zhou1, Weiting Xu, Jianchang Chen.   

Abstract

OBJECTIVE: The present study was designed to investigate the potential association between the 981C>T polymorphism in protein tyrosine phosphatase 1B (PTP-1B) and coronary artery disease (CAD).
METHODS: We conducted a hospital-based case-control study with 864 CAD patients and 1008 controls to explore the association between the PTP-1B 981C>T polymorphism and risk of CAD in Chinese Han population.
RESULTS: Subjects with the variant genotypes (CT+TT) had a 52% decreased risk of CAD relative to CC carriers (adjusted odds ratio, 0.48; 95% confidence interval, 0.39-0.60). The 981C>T polymorphism was associated with a higher body mass index and serum triglyceride levels in both CAD patients and controls. Moreover, this polymorphism was found to be associated with a lower serum glucose levels in cases, but not in controls.
CONCLUSION: Our study demonstrates that the PTP-1B 981C>T polymorphism is associated with decreased risk of CAD in Chinese Han population.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676396     DOI: 10.1016/j.atherosclerosis.2011.05.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Association of ACP1 gene polymorphisms and coronary artery disease in northeast Chinese population.

Authors:  Tianbao Li; Xuesong Xu; Jianzhuo Li; Shu Xing; Lin Zhang; Wannan Li; Junfeng Ma; Xueqi Fu
Journal:  J Genet       Date:  2015-03       Impact factor: 1.166

2.  Association between phosphatase related gene variants and coronary artery disease: case-control study and meta-analysis.

Authors:  Xia Han; Lijun Zhang; Zhiqiang Zhang; Zengtang Zhang; Jianchun Wang; Jun Yang; Jiamin Niu
Journal:  Int J Mol Sci       Date:  2014-08-13       Impact factor: 5.923

3.  Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway.

Authors:  Geneviève Hamel-Côté; Daniel Gendron; Marek Rola-Pleszczynski; Jana Stankova
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

4.  Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia.

Authors:  Alexey A Lagunin; Sergey M Ivanov; Tatyana A Gloriozova; Pavel V Pogodin; Dmitry A Filimonov; Sandeep Kumar; Rajesh K Goel
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.